Lipella Pharmaceuticals Common Stock Probability of Future Stock Price Finishing Over 2.63
| LIPO Stock | 3.02 0.03 1.00% |
Lipella |
Lipella Pharmaceuticals Target Price Odds to finish over 2.63
The tendency of Lipella Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 2.63 in 90 days |
| 3.02 | 90 days | 2.63 | about 90.19 |
Based on a normal probability distribution, the odds of Lipella Pharmaceuticals to stay above 2.63 in 90 days from now is about 90.19 (This Lipella Pharmaceuticals Common probability density function shows the probability of Lipella Stock to fall within a particular range of prices over 90 days) . Probability of Lipella Pharmaceuticals price to stay between 2.63 and its current price of 3.02 at the end of the 90-day period is about 26.83 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.97 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Lipella Pharmaceuticals will likely underperform. Additionally Lipella Pharmaceuticals Common has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Lipella Pharmaceuticals Price Density |
| Price |
Predictive Modules for Lipella Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lipella Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Lipella Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lipella Pharmaceuticals is not an exception. The market had few large corrections towards the Lipella Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lipella Pharmaceuticals Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lipella Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 2.97 | |
σ | Overall volatility | 0.41 | |
Ir | Information ratio | -0.0026 |
Lipella Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lipella Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lipella Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lipella Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 449.62 K. Net Loss for the year was (4.62 M) with loss before overhead, payroll, taxes, and interest of (2.36 M). | |
| Lipella Pharmaceuticals generates negative cash flow from operations | |
| Lipella Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| About 29.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investing.com: Lipella Pharmaceuticals reschedules special meeting |
Lipella Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lipella Stock often depends not only on the future outlook of the current and potential Lipella Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipella Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6 M | |
| Cash And Short Term Investments | 3.3 M |
Lipella Pharmaceuticals Technical Analysis
Lipella Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Lipella Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lipella Pharmaceuticals Common. In general, you should focus on analyzing Lipella Stock price patterns and their correlations with different microeconomic environments and drivers.
Lipella Pharmaceuticals Predictive Forecast Models
Lipella Pharmaceuticals' time-series forecasting models is one of many Lipella Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lipella Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lipella Pharmaceuticals
Checking the ongoing alerts about Lipella Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lipella Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lipella Pharmaceuticals had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 449.62 K. Net Loss for the year was (4.62 M) with loss before overhead, payroll, taxes, and interest of (2.36 M). | |
| Lipella Pharmaceuticals generates negative cash flow from operations | |
| Lipella Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| About 29.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from investing.com: Lipella Pharmaceuticals reschedules special meeting |
Check out Lipella Pharmaceuticals Backtesting, Lipella Pharmaceuticals Valuation, Lipella Pharmaceuticals Correlation, Lipella Pharmaceuticals Hype Analysis, Lipella Pharmaceuticals Volatility, Lipella Pharmaceuticals History as well as Lipella Pharmaceuticals Performance. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipella Pharmaceuticals. If investors know Lipella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipella Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.88) | Revenue Per Share 0.592 | Quarterly Revenue Growth 0.279 | Return On Assets (0.94) | Return On Equity (1.72) |
The market value of Lipella Pharmaceuticals is measured differently than its book value, which is the value of Lipella that is recorded on the company's balance sheet. Investors also form their own opinion of Lipella Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lipella Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipella Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lipella Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipella Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipella Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipella Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.